<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01219608</url>
  </required_header>
  <id_info>
    <org_study_id>eums1388</org_study_id>
    <nct_id>NCT01219608</nct_id>
  </id_info>
  <brief_title>Iranian Intensive Care Unit (ICU) Glutamine Study</brief_title>
  <official_title>Iranian Intensive Care Unit (ICU) Glutamine Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blinded placebo-controlled block randomized study in intensive care patients
      comparing enteral glutamine supplementation to placebo. The hypothesis is an improvement of
      clinical and paraclinical outcomes. The primary endpoint is Infection Probability Score (IPS)
      and Systemic Inflammatory Response Syndrome (SIRS). Anthropometric measures and serum
      inflammatory mediators will be compared.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infection Probability Score</measure>
    <time_frame>10 days after intervention</time_frame>
    <description>Infection Probability Score will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systemic Inflammatory Response Syndrome</measure>
    <time_frame>10 days after intervention</time_frame>
    <description>Systemic Inflammatory Response Syndrome will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prealbumin</measure>
    <time_frame>10 days after intervention</time_frame>
    <description>Prealbumin will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>10 days after intervention</time_frame>
    <description>CRP will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum prealbumin</measure>
    <time_frame>10 days after the intervention</time_frame>
    <description>Prealbumin will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay (LOS)</measure>
    <description>LOS will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bed sores</measure>
    <time_frame>10 days after intervention</time_frame>
    <description>Bed sores will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation</measure>
    <time_frame>10 days after intervention</time_frame>
    <description>Mean mechanical ventilation need will be measured and will be compared to the baseline after 10 days of the intervention</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Trauma Patients in ICU</condition>
  <arm_group>
    <arm_group_label>Glutamine 0.5 g/kg/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Glutamine 1 g/kg/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Enteral Nutrition</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glutamine 0.5 g/kg/day</intervention_name>
    <description>Glutamine 0.5 g/kg/day</description>
    <arm_group_label>Glutamine 0.5 g/kg/day</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glutamine 1 g/kg/day</intervention_name>
    <description>Glutamine 1 g/kg/day</description>
    <arm_group_label>Glutamine 1 g/kg/day</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enteral Nutrition</intervention_name>
    <description>Ordinary Enteral Nutrition</description>
    <arm_group_label>Enteral Nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-60

          -  No corticosteroids use

          -  No history of heart, liver and kidney diseases

          -  Nutrition through nasogastric or orogastric

        Exclusion Criteria:

          -  Patients who will not tolerate enteral nutrition for more than 48 hours

          -  Patients who are NPO and nutritional support has not started

          -  Lactating and pregnant women

          -  Kidney failure during the study

          -  A history of glutamin supplement use before the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Al-Zahra Hospital</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2010</study_first_submitted>
  <study_first_submitted_qc>October 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2010</study_first_posted>
  <last_update_submitted>June 13, 2011</last_update_submitted>
  <last_update_submitted_qc>June 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr Reza Rastmanesh</name_title>
    <organization>Shahid Beheshti University of Medical Sciences</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

